MedTrace Logo

Progressive Relaxation Training in Breast Cancer Patients Receiving Aromatatase Inhibitor Therapy

NCT04163692 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2021-04-01

No results posted yet for this study

Summary

This study evaluates the effects of progressive relaxation exercises on artralgia, quality of life and anxiety-deppression in breast cancer patients receiving aromatase inhibitor. Half of the participants will receive supervised progressive relaxing exercises, while other half will not receive any exercise but only advice about relaxing.

Hypothesis: Progressive relaxation exercises improve the pain, quality of life and emotional status in breast cancer patients receiving aromatase inhibitor therapy.

Conditions

Interventions

OTHER

Progressive relaxation exercises

Following intructions have been performed by patients: * Punch your hands and contract your forearm * Punch your hands, push your elbow towards the seat * Bend your elbows * Push your shoulders back * Press your knee down and pull your toes towards you * Pull your knees towards you and push your feet down * Tighten your hips * Push your head back * Lift your eyebrows * Make wrinkles on your nose * Tighten your teeth * Push your chin down * Close your eyes and think of good things.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Umut Bahcacı, MSc · Florence Nightingale Hospital, Istanbul

  • Zeynep Erdoğan İyigün, Asst. Prof. · Florence Nightingale Hospital, Istanbul

  • Songul Atasavun Uysal, Prof. · Hacettepe University

  • Çetin Ordu, Asst. Prof. · Florence Nightingale Hospital, Istanbul

  • Vahit Özmen, Prof. · Florence Nightingale Hospital, Istanbul

  • Gürsel Remzi Soybir, Prof. · Memorial Etiler Health Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-25
Primary Completion
2020-09-24
Completion
2020-09-24

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04163692 on ClinicalTrials.gov